Latest Regenerative Cancer News

European Commission Approves Zemcelpro®: First Sole Cell Therapy for Blood Cancer Patients Lacking Suitable Donors

Zemcelpro® offers a new stem cell transplant option for adults with blood cancers unable to find compatible donors in Europe.

FDA Grants Fast Track Status to Stem Cell-Viral Therapy for Advanced Cancers

Calidi’s CLD-201, a novel stem cell-based oncolytic virus therapy, moves forward.

Organ donor? That may include using your stem cells: first successful transplant using deceased donor in blood Cancer clinical trial

It's interesting to consider, much like with umbilical cords, how often are we incinerating life-saving stem cells?

BrainChild Bio granted FDA RMAT designation for its CAR T-cell therapy for incurable pediatric brain tumors

The company plans on moving to Phase 2 later this year, hopefully supporting a BLA in the near future.

Allogene Therapeutics Receives Three FDA Fast Track Designations for Lupus, Myositis, and Scleroderma Allogeneic CAR T Therapies

Allogene Therapeutics' dual-targeted CAR T therapy, ALLO-329, receives three FDA Fast Track designations, accelerating development for severe autoimmune conditions including lupus, myositis, and systemic sclerosis.
x
Subscribe
Subscribe

Stay updated on Regenerative Medicine

Subscribe